blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1721971

EP1721971 - SCREENING METHOD [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  25.01.2013
Database last updated on 09.09.2024
Most recent event   Tooltip25.01.2013Application deemed to be withdrawnpublished on 27.02.2013  [2013/09]
Applicant(s)For all designated states
Eisai R&D Management Co., Ltd.
6-10, Koishikawa 4-chome, Bunkyo-ku
Tokyo 112-8088 / JP
[2006/46]
Inventor(s)01 / HIDA, Takayuki, c/o Eisai Co., Ltd.
Tsukuba Research Laboratories, 5-1-3, Tokodai
Tsukuba-shi, Ibaraki 3002635 / JP
02 / SEKIYA, Tomoko, c/o Eisai Co., Ltd.
Tsukuba Research Labs, 1-3, Tokodai 5-chome
Tsukuba-shi, Ibaraki 3002635 / JP
03 / SAWAI, Toru, c/o Eisai Co., Ltd.
Tsukuba Research Laboratories, 5-1-3, Tokodai
Tsukuba-shi, Ibaraki 3002635 / JP
04 / SEIKI, Takashi, c/o Eisai Co., Ltd.
Tsukuba Research Laboratories, 5-1-3, Tokodai
Tsukuba-shi, Ibaraki 3002635 / JP
05 / TAKAHASHI, Eiki
1-9-14-502, Minami-Nagareyama
Nagareyama-shi, Chiba-ken 2700163 / JP
06 / KOSASA, Michiko, c/o Eisai Co., Ltd.
Tsukuba Research Laboratories, 5-1-3, Tokodai
Tsukuba-shi, Ibaraki 3002635 / JP
07 / HARADA, Kokichi, c/o Eisai Co., Ltd.
Tsukuba Research Laboratories, 1-3, Tokodai
Tsukuba-shi, Ibaraki 3002635 / JP
08 / ARAI, Toru, c/o Eisai Co., Ltd.
Tsukuba Research Laboratories, 5-1-3, Tokodai
Tsukuba-shi, Ibaraki 3002635 / JP
 [2006/47]
Former [2006/46]01 / HIDA, Takayuki, c/o Eisai Co., Ltd.
Tsukuba Research Laboratories, 5-1-3, Tokodai
Tsukuba-shi, Ibaraki 3002635 / JP
02 / SEKIYA, Tomoko, c/o Eisai Co., Ltd.
Tsukuba Research Labs, 1-3, Tokodai 5-chome
Tsukuba-shi, Ibaraki 3002635 / JP
03 / SAWAI, Toru, c/o Eisai Co., Ltd.
Tsukuba Research Laboratories, 5-1-3, Tokodai
Tsukuba-shi, Ibaraki 3002635 / JP
04 / SEIKI, Takashi, c/o Eisai Co., Ltd.
Tsukuba Research Laboratories, 5-1-3, Tokodai
Tsukuba-shi, Ibaraki 3002635 / JP
05 / TAKAHASHI, Eiki, c/o Eisai Co., Ltd.
Tsukuba Research Laboratories, 5-1-3, Tokodai
Tsukuba-shi, Ibaraki 3002635 / JP
06 / KOSASA, Michiko, c/o Eisai Co., Ltd.
Tsukuba Research Laboratories, 5-1-3, Tokodai
Tsukuba-shi, Ibaraki 3002635 / JP
07 / HARADA, Kokichi, c/o Eisai Co., Ltd.
Tsukuba Research Laboratories, 1-3, Tokodai
Tsukuba-shi, Ibaraki 3002635 / JP
08 / ARAI, Toru, c/o Eisai Co., Ltd.
Tsukuba Research Laboratories, 5-1-3, Tokodai
Tsukuba-shi, Ibaraki 3002635 / JP
Representative(s)Gillard, Richard Edward
Elkington and Fife LLP
Thavies Inn House
3-4 Holborn Circus
London EC1N 2HA / GB
[N/P]
Former [2009/45]Gillard, Richard Edward
Elkington and Fife LLP Thavies Inn House 3-4 Holborn Circus
London EC1N 2HA / GB
Former [2006/46]Gillard, Richard Edward
Elkington and Fife LLP, Prospect House 8 Pembroke Road Sevenoaks
Kent TN13 1XR / GB
Application number, filing date05709939.209.02.2005
[2006/46]
WO2005JP01887
Priority number, dateJP2004003159109.02.2004         Original published format: JP 2004031591
JP2004036850920.12.2004         Original published format: JP 2004368509
[2006/46]
Filing languageJA
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2005075641
Date:18.08.2005
Language:EN
[2005/33]
Type: A1 Application with search report 
No.:EP1721971
Date:15.11.2006
Language:EN
The application published by WIPO in one of the EPO official languages on 18.08.2005 takes the place of the publication of the European patent application.
[2006/46]
Search report(s)International search report - published on:JP18.08.2005
(Supplementary) European search report - dispatched on:EP29.08.2007
ClassificationIPC:C12N15/09, C12Q1/02, C07K14/435, C07K14/705, A61K38/00, A61P1/00, A61P3/04, G01N33/15
[2006/46]
CPC:
A61K38/17 (EP,US); C07K14/435 (KR); A61K38/00 (KR);
A61P1/00 (EP); A61P25/00 (EP); A61P25/30 (EP);
A61P3/00 (EP); A61P3/04 (EP); A61P3/10 (EP);
A61P35/00 (EP); A61P43/00 (EP); C07K14/705 (KR);
C12N15/09 (KR); G01N33/566 (EP,US); G01N2500/04 (EP,US);
Y02A50/30 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2006/46]
Extension statesAL19.07.2006
BA19.07.2006
HR19.07.2006
LVNot yet paid
MK19.07.2006
YU19.07.2006
TitleGerman:SCREENING-VERFAHREN[2006/46]
English:SCREENING METHOD[2006/46]
French:PROCEDE DE TEST DE SELECTION[2006/46]
Entry into regional phase18.07.2006Translation filed 
19.07.2006National basic fee paid 
19.07.2006Search fee paid 
19.07.2006Designation fee(s) paid 
19.07.2006Examination fee paid 
Examination procedure19.07.2006Examination requested  [2006/46]
27.10.2006Amendment by applicant (claims and/or description)
29.08.2008Despatch of a communication from the examining division (Time limit: M04)
08.01.2009Reply to a communication from the examining division
22.10.2010Despatch of a communication from the examining division (Time limit: M04)
22.02.2011Reply to a communication from the examining division
01.09.2012Application deemed to be withdrawn, date of legal effect  [2013/09]
10.10.2012Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time  [2013/09]
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  29.08.2008
Fees paidRenewal fee
14.02.2007Renewal fee patent year 03
13.02.2008Renewal fee patent year 04
13.02.2009Renewal fee patent year 05
16.02.2010Renewal fee patent year 06
15.02.2011Renewal fee patent year 07
Penalty fee
Additional fee for renewal fee
29.02.201208   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]WO03030930  (FLOREY HOWARD INST [AU], et al) [A] 1-35 * the whole document *;
 [A]  - LIU C ET AL, "Identification of relaxin-3/INSL7 as an endogenous ligand for the orphan G-protein-coupled receptor GPCR135", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY OF BIOLOCHEMICAL BIOLOGISTS, BIRMINGHAM,, US, (20031212), vol. 278, no. 50, ISSN 0021-9258, pages 50754 - 50764, XP002319829 [A] 1-35 * page 50763, column 2, line 3 - line 6 *

DOI:   http://dx.doi.org/10.1074/jbc.M308995200
International search[AP]WO2004112575  (TULARIK INC [US], et al);
 [A]WO03030930  (FLOREY HOWARD INST [AU], et al)
 [A]  - LIU C. ET AL, "Identification of relaxin-3/INSL7 as an endogenous ligand for the orphan G-protein-coupled receptor GPCR135", J BIOL CHEM, (2003), vol. 278, no. 50, pages 50754 - 50764, XP002319829

DOI:   http://dx.doi.org/10.1074/jbc.M308995200
 [A]  - LIU C. ET AL, "Identification of relaxin-3/INSL7 as a ligand for GPCR142", J BIOL CHEM, (2003), vol. 278, no. 50, pages 50765 - 50770, XP002987509

DOI:   http://dx.doi.org/10.1074/jbc.M308996200
 [A]  - BATHGATE R.A. ET AL, "Relaxin: new peptides, receptors and novel actions", TRENDS ENDOCRINOL METAB, (2003), vol. 14, no. 5, pages 207 - 213, XP002987510

DOI:   http://dx.doi.org/10.1016/S1043-2760(03)00081-X
 [A]  - KIZAWA H. ET AL, "Production of recombinant human relaxin 3 in AtT20 cells", REGUL PEPT, (2003), vol. 113, no. 1-3, pages 79 - 84, XP002987511
 [A]  - SUDO S. ET AL, "H3 relaxin is a specific ligand for LGR7 and activates the receptor by interacting with both the ectodomain and the exoloop 2", J BIOL CHEM, (2003), vol. 278, no. 10, pages 7855 - 7862, XP002987512

DOI:   http://dx.doi.org/10.1074/jbc.M212457200
 [A]  - SAMUEL C.S. ET AL, "Physiological or pathological--a role for relaxin in the cardiovascular system", CURR OPIN PHARMACOL, (2003), vol. 3, no. 2, pages 152 - 158, XP002987513

DOI:   http://dx.doi.org/10.1016/S1471-4892(03)00011-0
by applicantWO0168862
 JP2002345468
 WO2004082598
 WO0024891
 WO0148189
 WO0231111
 WO02061087
 WO03030930
    - SPIEGELMAN ET AL., CELL, (2001), vol. 104, pages 541 - 543
    - SINNAYAH ET AL., ENDOCRINOLOGY, (1999), vol. 140, pages 5082 - 5086
    - BATHGATE ET AL., J. BIOL. CHEM., (2002), vol. 277, pages 1148 - 1157
    - SUDO ET AL., J. BIOL. CHEM., (2003), vol. 278, pages 7855 - 7862
    - TAKEDA ET AL., FEBS LETTER, (2002), vol. 520, pages 97 - 101
    - LIU ET AL., J. BIOL. CHEM., (2003), vol. 278, pages 50754 - 50764
    - MATSUMOTOETAL, GENE, (2000), vol. 248, pages 183 - 189
    - LIU ET AL., J. BIOL. CHEM., (2003), vol. 278, pages 50765 - 50770
    - BOELS ET AL., BR. J. PHARMACOL ., (2003), vol. 140, pages 932 - 938
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.